Skip to content

Imaging Human Cognition

Imaging Human Cognition - Imaging Human Cognition

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55541
Enrollment
15000
Registered
2014-08-27
Start date
2014-09-25
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

exploratief neurowetenschappelijk onderzoek brain research human cognition

Interventions

None listed

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
16 Years to 99 Years

Inclusion criteria

Inclusion criteria: Competent adolescents and adult volunteers (>=16 years of age) Normal or to normal corrected vision Normal-uncorrected hearing Willingness and ability to understand nature and content of the study and give informed consent Ability to participate and comply to study requirements

Exclusion criteria

Exclusion criteria: History of or current neurological treatment Current psychiatric diagnosis and/or treatment History of or current brain surgery or epilepsy Pregnancy Method-specific exclusion criteria. For an MRI study this is e.g., metal in the upper body and claustrophobia. These are further specified in the method-specific screening forms

Design outcomes

Primary

MeasureTime frame
(f)MRI, MEG, EEG, fNIRS, behavioural research through neuropsychological tasks, questionnaires, behavioural or neuroimaging parameters in relation to t(A/D)CS.

Secondary

MeasureTime frame
Electrodermal activity (EDA), heart rate, breathing rate, eye-tracking, surface electromyography (EMG), blood pressure, hormone levels assessed from saliva and/or urine samples, questionnaires, BMI, online testing, experience sampling/ecological momentary assessment through a smartphone or wearables, relevant participant characteristics such as age, handedness, colour blindness, hearing problems, (native) language, education level and other relevant demographic information necessary for the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)